Safety and Feasibility Using a Fluid-Filled Wire to Avoid Hydrostatic Errors in Physiological Intracoronary Measurements
- PMID: 38204600
- PMCID: PMC10776192
- DOI: 10.1155/2024/6664482
Safety and Feasibility Using a Fluid-Filled Wire to Avoid Hydrostatic Errors in Physiological Intracoronary Measurements
Abstract
Background: Using a fluid-filled wire with a pressure sensor outside the patient compared to a conventional pressure wire may avoid the systematic error introduced by the hydrostatic pressure within the coronary circulation.
Aims: To assess the safety and effectiveness of the novel fluid-filled wire, Wirecath (Cavis Technologies, Uppsala, Sweden), as well as its ability to avoid the hydrostatic pressure error.
Methods and results: The Wirecath pressure wire was used in 45 eligible patients who underwent invasive coronary angiography and had a clinical indication for invasive coronary pressure measurement at Sahlgrenska University Hospital, Gothenburg, Sweden. In 29 patients, a simultaneous measurement was performed with a conventional coronary pressure wire (PressureWire X, Abbott Medical, Plymouth, MN, USA), and in 19 patients, the vertical height difference between the tip of the guide catheter and the wire measure point was measured in a 90-degree lateral angiographic projection. No adverse events caused by the pressure wires were reported. The mean Pd/Pa and mean FFR using the fluid-filled wire and the sensor-tipped wire differed significantly; however, after correcting for the hydrostatic effect, the sensor-tipped wire pressure correlated well with the fluid-filled wire pressure (R = 0.74 vs. R = 0.89 at rest and R = 0.89 vs. R = 0.98 at hyperemia).
Conclusion: Hydrostatic errors in physiologic measurements can be avoided by using the fluid-filled Wirecath wire, which was safe to use in the present study. This trial is registered with NCT04776577 and NCT04802681.
Copyright © 2024 Truls Råmunddal et al.
Conflict of interest statement
Oskar Angerås is a member of the advisory board of Cavis Technologies and a member of the advisory board of Abbott Vascular. He received research grant from Abbott Vascular and speaker fee from Abbott Vascular, Boston Scientific, and Medtronic. Petur Petursson received speaker fee from Medtronic. Sebastian Völz received speaker fee from Abbott Vascular and Boston Scientific. Mats Hilmersson is an employee at Cavis Technologies AB.
Figures






References
-
- Lawton J. S., Tamis-Holland J. E., Bangalore S., et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of Cardiology/American heart association joint committee on clinical practice guidelines. Circulation . 2022;145(3):e4–e17. doi: 10.1161/cir.0000000000001039. - DOI - PubMed
-
- Lee J. M., Rhee T. M., Choi K. H., et al. Clinical outcome of lesions with discordant results among different invasive physiologic indices ― resting distal coronary to aortic pressure ratio, resting full-cycle ratio, diastolic pressure ratio, instantaneous wave-free ratio, and fractional flow reserve. Circulation Journal . 2019;83(11):2210–2221. doi: 10.1253/circj.cj-19-0230. - DOI - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical